SEC Form 4 · accession 0001104659-17-042168
Clovis Oncology, Inc. · CLVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian G Atwood
Director
Period of report
Jun 26, 2017
Accepted (ET)
Jun 28, 2017 · 6:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001466301
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 26, 2017 | J | 212 | $0.00 | A | 20,579 | I | See Footnote |
| Common StockF2 | Jun 26, 2017 | J | 4,998 | $0.00 | A | 25,577 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a change in the form of ownership by virtue of the receipt of shares in the pro-rata distribution of Common Stock of the Issuer by Versant Side Fund IV, L.P. without consideration to its partners.
- F2The shares are held by the Atwood-Edminster Trust dated 4/2/2000 (the "Trust"). Brian G. Atwood (the "Reporting Person") is a trustee and a named beneficiary of the Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his proportionate pecuniary interest therein.
- F3Represents a change in the form of ownership by virtue of the receipt of shares in the pro-rata distribution of Common Stock of the Issuer by Versant Ventures IV, LLC without consideration to its members.